The role of saroglitazar in the treatment of prediabetes and elevated lipid levels
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Prediabetes with dyslipidemia
- Registration Number
- CTRI/2016/03/006778
- Lead Sponsor
- Deogiri Diabetes Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Willing to participate in the study and follow protocol.
Patients of either sex with age group of 20-60 years.
Prediabetic patients with HbA1c 5.7- 6.5 % and deranged lipids as per NCEP guidelines.
Exclusion Criteria
Type 1 diabetes mellitus
Type 2 diabetes
Secondary hypertension.
Bronchial asthma.
Chronic obstructive pulmonary disease.
Any other respiratory disorders.
g.Any Hepatic or renal diseases.
h.Any other cardiovascular disorder.
ï??Pregnant and lactating women.
ï??History of known allergy to drugs.
ï??Patient concurrently taking other medication which is known to affect the blood sugar and lipid parameters.
ï??Smoker, alcoholic and tobacco chewer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method